1,2,4,5-Tetramethylbenzene
Common Name: |
1,2,4,5-Tetramethylbenzene |
IUPAC Name: |
1,2,4,5-tetramethylbenzene |
Molecular Formula: |
C10H14 |
SMILES: |
CC1=CC(=C(C=C1C)C)C |
Inchi: |
1S/C10H14/c1-7-5-9(3)10(4)6-8(7)2/h5-6H,1-4H3 |
Inchi Key: |
SQNZJJAZBFDUTD-UHFFFAOYSA-N |
Cas No: |
95-93-2 |
Name |
Value |
Lipinski Violations |
1 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
134.22 |
Mass (g/mol) |
134.11 |
Molar Refractivity |
46.31 |
Net Charge |
|
HBD |
|
HBA |
0 |
Rt Bonds |
0 |
Rings |
1 |
TPSA |
0.00 |
Hetero Atoms |
0 |
Heavy Atoms |
10 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
78.00 to 79.00 |
Boiling Point (°C@760.00mm Hg) |
196.00 to 198.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.696 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.40 |
LogP |
2.92 |
iLOGP |
2.47 |
XLOGP3 |
4.00 |
WLOGP |
2.92 |
MLOGP |
4.47 |
ESOL Log S |
-3.64 |
ESOL Solubility (mg/ml) |
0.031 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.70 |
Ali Solubility (mg/ml) |
0.03 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.91 |
Silicos-IT Solubility (mg/ml) |
0.02 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
Low |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.28 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.792 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
1 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.511 |
Carcinogenicity (Binary) |
1 |
Carcinogenicity (Trinary) |
Warning |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |